• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于静脉注射碘对比剂给药前使用预用药的实践放射科医生调查。

A Survey of Practicing Radiologists on the Use of Premedication Before Intravenous Iodinated Contrast Medium Administration.

机构信息

Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts; Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut; Chair, ACR RFS Women and Diversity Advisory Group; and Past-Past President, RFS of Radiological Society of Connecticut. Electronic address: https://twitter.com/fsodagari.

Service Chief and Vice Chair in Department of Radiology, Michigan Medicine, Ann Arbor, Michigan; Vice Chair of the Commission on Quality and Safety for ACR; and Board of Directors for Society of Advanced Body Imaging. Electronic address: https://twitter.com/MattDavenportMD.

出版信息

J Am Coll Radiol. 2024 May;21(5):795-804. doi: 10.1016/j.jacr.2023.04.024. Epub 2023 Jul 27.

DOI:10.1016/j.jacr.2023.04.024
PMID:37516161
Abstract

OBJECTIVE

To determine whether updated guidance by the ACR in 2017 advocating use of intravenous (IV) premedication in emergency department (ED) patients and inpatients with reported iodinated contrast allergy was associated with a change in clinical practice.

METHODS

An anonymous survey was distributed via e-mail in October 2020 to practicing radiologist members of the ACR interrogating use of corticosteroid premedication for two clinical vignettes: an indicated routine (perform within 24 hours) inpatient contrast-enhanced CT (CE-CT) and an indicated urgent (perform within 6 hours) ED CE-CT. In both scenarios, the patient had a prior moderate hypersensitivity reaction to iodinated contrast media. Clinical management was evaluated. Data were compared to historical controls from 2009.

RESULTS

The response rate was 11% (724 of 6,616). For the inpatient scenario, 72% (518 of 724) would use corticosteroid premedication with CE-CT, and 28% (200 of 724) would perform noncontrast CT. For the ED scenario, 67% (487 of 724) would use corticosteroid premedication with CE-CT, and 30% (217 of 724) would perform noncontrast CT. Oral premedication (85%, 439 of 518) was preferred for routine inpatients, and rapid IV premedication (89%, 433 of 487) was preferred for urgent ED patients. Of those who provided rapid IV dosing data in the ED, two doses of corticosteroids were used by 53% (216 of 410) and one dose was used by 45% (185 of 410), with academic radiologists more likely than private or hybrid practice radiologists to administer two doses (74% [74 of 100] versus 48% [151 of 312], P < .001, odds ratio, 3.03; 95% confidence interval, 1.84-5.00). Rapid IV premedication was more commonly used in 2020 than in 2009 (60% [433 of 724] versus 29% [20 of 69], P < .001, odds ratio, 3.65; 95% confidence interval, 2.12-6.26). Antihistamine use was common in both inpatient (93%, 480 of 518) and ED settings (92%, 447 of 487). Only 32% (229 of 721) of radiologists practiced in accordance with ACR guidelines, suggesting no need for routine premedication before CE-CT in patients with prior severe hypersensitivity reaction to gadolinium-based contrast media. Nonetheless, most (93%, 670 of 724) said the ACR Manual on Contrast Media was a major determinant of their practice.

CONCLUSIONS

Use of rapid IV premedication in urgent settings has increased since 2009, following updated ACR guidelines, but there is disagreement over whether one or two corticosteroid doses is required. Despite reported high reliance on ACR guidelines, deviations from those guidelines remain common. In general, when ACR guidelines were not followed, it was in a risk-averse direction.

摘要

目的

确定 2017 年 ACR 更新的指南是否提倡在急诊室 (ED) 患者和报告对碘造影剂过敏的住院患者中使用静脉 (IV) 预用药,以及这是否与临床实践的改变有关。

方法

2020 年 10 月,通过电子邮件向 ACR 的放射科执业医师成员发送了一份匿名调查,询问了两种临床情况是否使用皮质类固醇预用药:有指征的常规 (24 小时内进行) 住院患者增强 CT (CE-CT) 和有指征的紧急 (6 小时内进行) ED CE-CT。在这两种情况下,患者均有中度碘造影剂过敏史。评估了临床管理。将数据与 2009 年的历史对照进行比较。

结果

应答率为 11%(724/6616)。对于住院患者情况,72%(518/724)会使用皮质类固醇预用药进行 CE-CT,28%(200/724)会进行非对比 CT。对于 ED 情况,67%(487/724)会使用皮质类固醇预用药进行 CE-CT,30%(217/724)会进行非对比 CT。对于有指征的住院患者,更倾向于口服预用药(85%,439/518),而对于紧急 ED 患者,则更倾向于快速 IV 预用药(89%,433/487)。在 ED 中提供快速 IV 给药数据的那些人中,53%(410 中的 216)使用了两剂皮质激素,45%(410 中的 185)使用了一剂皮质激素,与私立或混合执业的放射科医生相比,学术放射科医生更有可能使用两剂(74%[100 中的 74]与 48%[312 中的 151],P<.001,优势比,3.03;95%置信区间,1.84-5.00)。与 2009 年相比,2020 年更常使用快速 IV 预用药(60%[724 中的 433]与 29%[69 中的 20],P<.001,优势比,3.65;95%置信区间,2.12-6.26)。在住院患者(93%,480/518)和 ED 环境中(92%,447/487)均普遍使用抗组胺药。只有 32%(721 中的 229)的放射科医生按照 ACR 指南进行实践,表明在有严重对钆类造影剂过敏史的患者中,CE-CT 前无需常规预用药。尽管大多数(93%,670/724)表示 ACR 造影剂手册是他们实践的主要决定因素。

结论

自 2009 年 ACR 更新指南以来,在紧急情况下使用快速 IV 预用药有所增加,但对于需要使用一剂还是两剂皮质激素存在分歧。尽管报告高度依赖 ACR 指南,但仍普遍存在偏离这些指南的情况。一般来说,当不遵循 ACR 指南时,都是以规避风险为导向的。

相似文献

1
A Survey of Practicing Radiologists on the Use of Premedication Before Intravenous Iodinated Contrast Medium Administration.一项关于静脉注射碘对比剂给药前使用预用药的实践放射科医生调查。
J Am Coll Radiol. 2024 May;21(5):795-804. doi: 10.1016/j.jacr.2023.04.024. Epub 2023 Jul 27.
2
Impact of iodinated contrast allergies on emergency department operations.碘化造影剂过敏对急诊科运营的影响。
Am J Emerg Med. 2022 Nov;61:127-130. doi: 10.1016/j.ajem.2022.08.052. Epub 2022 Sep 5.
3
Patterns of intravenous contrast material use and corticosteroid premedication in children--a survey of Society of Chairs of Radiology in Children's Hospitals (SCORCH) member institutions.儿科静脉内造影剂使用和皮质类固醇类药物预给药模式——对儿科放射学主席学会(SCORCH)成员机构的调查。
Pediatr Radiol. 2011 Oct;41(10):1272-83. doi: 10.1007/s00247-011-2112-5. Epub 2011 May 19.
4
Rates of Breakthrough Reactions in Inpatients at High Risk Receiving Premedication Before Contrast-Enhanced CT.接受造影增强CT前预防性用药的高危住院患者的突破性反应发生率。
AJR Am J Roentgenol. 2015 Jul;205(1):77-84. doi: 10.2214/AJR.14.13810.
5
Intravenous Corticosteroid Premedication Administered 5 Hours before CT Compared with a Traditional 13-Hour Oral Regimen.静脉注射皮质类固醇预给药与传统的 13 小时口服方案相比,在 CT 检查前 5 小时给药。
Radiology. 2017 Nov;285(2):425-433. doi: 10.1148/radiol.2017170107. Epub 2017 Jul 26.
6
Immediate Mild Reactions to CT with Iodinated Contrast Media: Strategy of Contrast Media Readministration without Corticosteroids.立即轻度反应 CT 碘造影剂:无皮质类固醇对比剂再管理策略。
Radiology. 2018 Sep;288(3):710-716. doi: 10.1148/radiol.2018172524. Epub 2018 May 22.
7
Outcomes of corticosteroid prophylaxis for hypersensitivity reactions to low osmolar contrast media in high-risk patients.高危患者中低渗造影剂过敏反应的皮质类固醇预防的结果。
Ann Allergy Asthma Immunol. 2016 Sep;117(3):304-309.e1. doi: 10.1016/j.anai.2016.07.010.
8
Allergic-like breakthrough reactions to gadolinium contrast agents after corticosteroid and antihistamine premedication.在使用皮质类固醇和抗组胺药进行预处理后,对钆对比剂出现类似过敏的突破性反应。
AJR Am J Roentgenol. 2008 Jan;190(1):187-90. doi: 10.2214/AJR.07.2718.
9
Stratified premedication strategy for the prevention of contrast media hypersensitivity in high-risk patients.高危患者中预防对比剂超敏反应的分层预处理策略。
Ann Allergy Asthma Immunol. 2017 Mar;118(3):339-344.e1. doi: 10.1016/j.anai.2016.11.027. Epub 2017 Jan 10.
10
Updated guidelines for intravenous contrast use for CT and MRI.更新的 CT 和 MRI 静脉造影剂使用指南。
Emerg Radiol. 2020 Apr;27(2):115-126. doi: 10.1007/s10140-020-01751-y. Epub 2020 Jan 10.

引用本文的文献

1
Computed tomography-based radiomics predicts prognostic and treatment-related levels of immune infiltration in the immune microenvironment of clear cell renal cell carcinoma.基于计算机断层扫描的放射组学可预测透明细胞肾细胞癌免疫微环境中免疫浸润的预后及治疗相关水平。
BMC Med Imaging. 2025 Jul 1;25(1):213. doi: 10.1186/s12880-025-01749-3.
2
Artificial intelligence-assisted double reading of chest radiographs to detect clinically relevant missed findings: a two-centre evaluation.人工智能辅助的胸部 X 光片双读以检测临床相关的遗漏发现:一项两中心评估。
Eur Radiol. 2024 Sep;34(9):5876-5885. doi: 10.1007/s00330-024-10676-w. Epub 2024 Mar 11.